Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 229

    1.

    How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

    Bouma M, Dekker JH, de Sonnaville JJ, van der Does FE, de Vries H, Kriegsman DM, Kostense PJ, Heine RJ, van Eijk JT.

    Diabetes Care. 1999 Jun;22(6):904-7.PMID: 10372239 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

    Davidson MB, Schriger DL, Peters AL, Lorber B.

    JAMA. 1999 Apr 7;281(13):1203-10. Erratum in: JAMA 1999 Jun 16;281(23):2187. PMID: 10199430 [PubMed - indexed for MEDLINE]Related articles

    4.

    Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control.

    el-Kebbi IM, Ziemer DC, Gallina DL, Phillips LS.

    Diabetes Care. 1998 Apr;21(4):501-5.PMID: 9571331 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

    Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

    Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.PMID: 17240473 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.

    Pecoraro RE, Koepsell TD, Chen MS, Lipsky BA, Belcher DW, Inui TS.

    Diabetes Care. 1986 Jul-Aug;9(4):370-5.PMID: 3743312 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

    Ko GT, Chan JC, Tsang LW, Cockram CS.

    Diabetes Care. 2000 Dec;23(12):1770-3.PMID: 11128350 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

    Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

    Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.

    Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J.

    Transplantation. 2009 Aug 15;88(3):429-34.PMID: 19667949 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.

    Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA.

    Diabetes Care. 1997 May;20(5):785-91.PMID: 9135943 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

    Miyazaki Y, Matsuda M, DeFronzo RA.

    Diabetes Care. 2002 Mar;25(3):517-23.PMID: 11874940 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

    Bonora E.

    Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.PMID: 12166607 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job]

    Jimeno Mollet J, Molist Brunet N, Franch Nadal J, Morató Griera J, Otzet Gramunt I, Pons Barro P.

    Aten Primaria. 2004 Sep 30;34(5):222-8. Spanish. PMID: 15456566 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

    Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R, Kamada T.

    Diabetes Care. 1995 Aug;18(8):1156-9.PMID: 7587851 [PubMed - indexed for MEDLINE]Related articles

    15.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    16.

    HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

    Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

    Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

    Avignon A, Radauceanu A, Monnier L.

    Diabetes Care. 1997 Dec;20(12):1822-6.PMID: 9405900 [PubMed - indexed for MEDLINE]Related articles

    18.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.

    Fonseca V.

    Curr Med Res Opin. 2003;19(7):635-41. Review.PMID: 14606987 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data